Makamashi da yanayi · Ayyukan da ake kan yi da ci gaba
IDEAYA Biosciences Ta Sanar da Zaɓin 'Dan Takarar Ci gaba na IDE101, Mai Hana Cutar da ta Farko a Irinsa wanda ke Nufin Rashin CDKN2A a Cikin Tumour Mai Ƙarfi
'Dan takarar ci gaba ya nuna aikin gwaji na farko mai ban sha'awa a cikin samfuran tumour marasa lafiya na CDKN2A azaman magani ɗaya kuma a haɗe tare da masu hana RAS da MTAP, gami da mai hana PRMT5 na Mataki na 1 na IDEAYA wanda yake mallakar ta IDE892 Rashin CDKN2A shine asarar mai hana tumour gama gari...
Asalin tushe
Karanta tushen — prnewswire.com ↗Muna haɗawa da ainihin mai wallafawa. Taƙaitawar da ke sama jagora ce kawai; karanta asalin don cikakken bayani.